Leerink Partners Forecasts Strong Price Appreciation for Cigna Group (NYSE:CI) Stock

Cigna Group (NYSE:CI) had its price target hoisted by investment analysts at Leerink Partners from $270.00 to $297.00 in a note issued to investors on Friday,MarketScreener reports. The brokerage presently has a “market perform” rating on the health services provider’s stock. Leerink Partners’ price target suggests a potential upside of 1.61% from the stock’s previous close.

CI has been the topic of a number of other reports. Royal Bank Of Canada lowered their price target on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday. Cantor Fitzgerald reduced their price objective on shares of Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. Wells Fargo & Company reduced their price target on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. Finally, Robert W. Baird dropped their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $323.16.

Cigna Group Stock Up 2.7%

CI opened at $292.29 on Friday. The stock has a market cap of $78.08 billion, a price-to-earnings ratio of 13.18, a price-to-earnings-growth ratio of 1.04 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The firm’s fifty day moving average is $274.77 and its 200 day moving average is $283.83. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the firm earned $6.64 earnings per share. The business’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in CI. Solstein Capital LLC purchased a new stake in Cigna Group during the second quarter valued at approximately $29,000. Harbor Capital Advisors Inc. raised its holdings in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares during the period. Chilton Capital Management LLC purchased a new stake in Cigna Group during the 2nd quarter valued at $30,000. Princeton Global Asset Management LLC lifted its position in Cigna Group by 115.6% in the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after buying an additional 52 shares during the last quarter. Finally, Beacon Financial Strategies CORP purchased a new position in Cigna Group during the fourth quarter worth $28,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.